Advanced Cell Technology said on Monday it had won U.S. Food and Drug Administration approval to try out human embryonic stem cells for treating macular degeneration, a common cause of vision loss.
Papildomos nuorodos
FDA approves second Advanced Cell stem cell trial
Šis įrašas paskelbtas Kamieninių ląstelių tyrimai kategorijose.
